| | | Single nucleotide variant (5 prime UTR variant +2 more) | not provided | |
| | NPHP3-ACAD11, UBA5 (M57V +1 more) | Single nucleotide variant (missense variant +2 more) | Developmental and epileptic encephalopathy, 44 +1 more | GConflicting classifications of pathogenicity |
| | UBA5, NPHP3-ACAD11 (R61* +1 more) | Single nucleotide variant (nonsense +1 more) | not provided | |
| | NPHP3-ACAD11, UBA5 (G168E +3 more) | Single nucleotide variant (missense variant) | Developmental and epileptic encephalopathy, 44 | |
| | NPHP3-ACAD11, UBA5 (R188* +3 more) | Single nucleotide variant (nonsense) | not provided +2 more | GPathogenic/Likely pathogenic |
| | NPHP3-ACAD11, UBA5 (V260M +3 more) | Single nucleotide variant (missense variant) | Developmental and epileptic encephalopathy, 44 | |
| | UBA5, NPHP3-ACAD11 (Y285* +3 more) | Single nucleotide variant (nonsense) | Developmental and epileptic encephalopathy, 44 | |
| | NPHP3-ACAD11, UBA5 (Q302* +3 more) | Single nucleotide variant (nonsense) | UBA5-related condition | |
| | NPHP3-ACAD11, UBA5 (K212fs +3 more) | Insertion (frameshift variant) | Developmental and epileptic encephalopathy, 44 | |
| | NPHP3-ACAD11, UBA5 (A371T +3 more) | Single nucleotide variant (missense variant) | UBA5-Related Disorders +5 more | GPathogenic/Likely pathogenic/Pathogenic, low penetrance |
| | NPHP3-ACAD11, UBA5 (D389Y +3 more) | Single nucleotide variant (missense variant) | Developmental and epileptic encephalopathy, 44 | |